ANR — Anatara Lifesciences Share News
0.000.00%
- AU$3.14m
- AU$2.05m
Australia Stock Exchange release from ANATARA LIFESCIE : Half Year Accounts
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 15:14:49
Australia Stock Exchange release from ANATARA LIFESCIE : Clinical Trials Update
Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4C and Q2 FY22 Activities Report
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 09:21:28
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 16:25:43
Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4C and Q2 FY22 Activities Report
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 09:28:57
Australia Stock Exchange release from ANATARA LIFESCIE : Clinical Trials Update
Australia Stock Exchange release from ANATARA LIFESCIE : Change of Director's Interest Notice
Australia Stock Exchange release from ANATARA LIFESCIE : Notification regarding unquoted securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Notification regarding unquoted securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Application for quotation of securities - ANR
Australia Stock Exchange release from ANATARA LIFESCIE : Anatara Strengthens the Team with New Appointments
Australia Stock Exchange release from ANATARA LIFESCIE : Results of Meeting
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 10:58:39
Australia Stock Exchange release from ANATARA LIFESCIE : AGM CEO Presentation
Australia Stock Exchange release from ANATARA LIFESCIE : PRE_NR Ends: 10:56:28
Australia Stock Exchange release from ANATARA LIFESCIE : Chairman's Address to Shareholders